R&D Sponsored Birmingham: The UK’s new epicentre of health innovation Birmingham has a rich history as a manufacturing and innovation powerhouse in the UK
News ASCO 25: Enhertu bids for earlier use in HER2+ breast cancer AstraZeneca and Daiichi Sankyo have revealed the data they hope will move Enhertu into frontline therapy for HER2-positive advanced breast cancer.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
